Health Services Research
Latest posts by Health Services Research (see all)
- Template Matching for Auditing Hospital Cost and Quality - Mar. 03, 2014
- The Burden of Inappropriate Emergency Department Pediatric Visits: Why Italy Needs an Urgent… - Feb. 05, 2014
- Regionalization and Local Hospital Closure in Norwegian Maternity Care—The Effect on Neonatal… - Jan. 30, 2014
- The Effects of Express Lane Eligibility on Medicaid and CHIP Enrollment among Children - Jan. 30, 2014
Objective To compare the use of guideline-recommended prescription medications for diabetes among Medicare beneficiaries enrolled in stand-alone prescription drug plans (PDPs) with Medicare Advantage prescription drug plans (MAPDs) in the presence of potential selection bias. Data Sources/Study Setting Centers for Medicare and Medicaid Services’ Chronic Condition Data Warehouse (2006, 2007). Study Design Retrospective cross-sectional comparison of drug use and proportion of days covered (PDC) for oral-antidiabetics, ACE-inhibitors/ARBs, and antihyperlipidemics among PDP and MAPD enrollees with diabetes. We estimated nave regression models assuming exogenous plan choice and two-stage residual inclusion (2SRI) models to study endogeneity in choice of Part D plan type.
Originally posted here: